BioSpace News Archive

In November 2013, Congress enacted The Drug Supply Chain Security Act (DSCSA), which has set off a list of changes for companies all along the pharmaceutical supply chain

Mood disorder, also known as affective disorder, is a mental health issue characterized by a serious change in mood that affects the person’s daily life

Evox Therapeutics Ltd, a leading exosome therapeutics company, announces that John McHutchison has joined its Board of Directors.

Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced the launch of the Omnipod DASH® Insulin Management System in Canada.

Today Syntegra and the National Institutes of Health (NIH) have announced a collaboration to validate Syntegra’s AI-enabled synthetic data technology to advance the understanding of and care for COVID-19. Using Sy

Resverlogix Corp. (“Resverlogix”, or the “Corporation”) (TSX:RVX) today announced that on January 28th, 2021 at 10:00 am MT, it will be hosting a webcast and conference call for the purpose of updating stakeholders regarding three key areas

Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient dosed in an investigator-initiated, randomized phase II, open-label clinical trial for its antiviral alisporivir (Debio 025).

Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company has received expressions of interest to evaluate proenzyme therapy as a method to prevent recurrence and metastasis of solid tumors in pancreatic and ovarian cancers.

Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics’ proprietary VELPTM platform to develop next-generation gene therapies.